Consonance Capital Management’s Merus Labs International Inc. MSLI Stock Holding History

Consonance Capital Management’s Portfolio MSLI Stock Details MSLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-28,484	Closed	-$47K	–	28
2015 Q4	$47K	Sell	28,484 -1,275,000	-98%	-$1.74M	0.01%	22
2015 Q3	$1.68M	Sell	1,303,484 -338,104	-21%	-$671K	0.24%	22
2015 Q2	$3.82M	Buy	1,641,588 +272,974	+20%	+$662K	0.38%	22
2015 Q1	$2.87M	Buy	1,368,614 +8,400	+0.6%	+$15.5K	0.26%	25
2014 Q4	$2.25M	Buy	+1,360,214	New	+$1.98M	0.29%	24

Other funds holding MSLI

1832 Asset Management Toronto, Ontario, Canada $200B AUM 30.19% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $126B AUM 27.87% 1-Year Est. Return

AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $47B AUM 34.17% 1-Year Est. Return

Intact Investment Management Montreal, Quebec, Canada $3.31B AUM 25.58% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

I.G. Investment Management Winnipeg, Manitoba, Canada $19.5B AUM 15.95% 1-Year Est. Return

Guardian Capital (Canada) Toronto, Ontario, Canada $4.2B AUM 18.67% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Consonance Capital Management's MSLI Position: Q1 2016 in Review

Consonance Capital Management sold out of Merus Labs International Inc. (MSLI) in Q1 2016, closing a stake of 28,484 shares — an estimated $47K sold.

Consonance Capital Management first reported a position in MSLI in Q4 2014 and held it in 5 quarters. The position peaked at $3.82M in Q2 2015. 29 funds tracked by Wall St. Rank hold MSLI as of Q1 2016.

Consonance Capital Management reported no remaining Merus Labs International Inc. position as of Q1 2016 after selling out during the quarter.
Consonance Capital Management sold 28,484 Merus Labs International Inc. shares in Q1 2016, an estimated $47K.
Consonance Capital Management first reported a position in Merus Labs International Inc. in Q4 2014 and held it in 5 quarters.
Consonance Capital Management's Merus Labs International Inc. position peaked at $3.82M in Q2 2015.
29 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q1 2016.

Based on Consonance Capital Management's 13F filing for Q1 2016, filed 16 May 2016.